Investors

News Releases

News Releases

June 28, 2022
SANTA MONICA, Calif. , June 28, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals , Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced the Compensation and Human Capital Committee of the Company’s
April 29, 2022
SANTA MONICA, Calif. , April 29, 2022 /PRNewswire/ --  Opiant Pharmaceuticals (NASDAQ: OPNT) was the subject of a fake news release issued on Friday, April 29, 2022 , that falsely stated Opiant announced a partnership with Hikma Pharmaceuticals, PLC.  Opiant had no knowledge of the press release